Skip to main
CME
CME logo

CME Group (CME) Stock Forecast & Price Target

CME Group (CME) Analyst Ratings

Based on 35 analyst ratings
Hold
Strong Buy 17%
Buy 23%
Hold 43%
Sell 9%
Strong Sell 9%

Bulls say

CME Group's strong performance in recent quarters is underscored by a 9% year-over-year increase in its quarterly dividend, which reflects robust free cash flow generation and a commitment to returning value to shareholders. The company has also experienced significant growth in various trading products, with Henry Hub Natural Gas futures attaining record levels and the Micro E-mini Dow Jones futures posting a 29% increase in average daily volume. Additionally, the substantial rise in crypto product trading—evidenced by a 307% year-over-year growth—alongside the continued expansion in options trading indicates a favorable outlook driven by increased customer demand and ongoing product innovation.

Bears say

CME Group is experiencing significant pressures in its agricultural commodity trading, with average daily volumes (ADV) declining, particularly in the soybean markets, due to favorable weather conditions in South America that could lead to record production. This downturn, coupled with diminished concerns over supply constraints in the cattle market, raises concerns about the potential for continued declines in open interest (OI), which might adversely affect market sentiment and financial conditions for CME shares. Although there was a modest increase in market data and information services revenue, the overall financial outlook remains tenuous, with EPS estimates sensitive to fluctuations in market performance, leading to a high-risk scenario for the company's valuation and future growth.

CME Group (CME) has been analyzed by 35 analysts, with a consensus rating of Hold. 17% of analysts recommend a Strong Buy, 23% recommend Buy, 43% suggest Holding, 9% advise Selling, and 9% predict a Strong Sell.

This aggregate rating is based on analysts' research of CME Group and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About CME Group (CME) Forecast

Analysts have given CME Group (CME) a Hold based on their latest research and market trends.

According to 35 analysts, CME Group (CME) has a Hold consensus rating as of Jul 1, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $211.86, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $211.86, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

CME Group (CME)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.